down arrow

Sandu Pharma.

  • Market Cap: Micro Cap
  • Industry: Trading
  • ISIN: INE751D01014
  • NSEID:
  • BSEID: 524703
INR
49.48
1.49 (3.1%)
BSENSE

Apr 11, 12:50 PM

BSE+NSE Vol: 1.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sandu Pharmaceuticals Ltd stock-summary
stock-summary
Sandu Pharmaceuticals Ltd
Micro Cap
Trading
Sandu Pharmaceuticals Ltd (SPL) was established in 1985. The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name SANDU. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
Company Coordinates stock-summary
Company Details
Plot No 25/26/29 & 30, Pilerne Indl Estate Marra Bard Bardez Goa : 403511
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 9.66 Cr
Number of Shares
96.61 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
14-Jul-2022
96.61
9.66
850326
10
Conversion of Warrants
29-Mar-2022
88.11
8.81
889667
10
Conversion of Warrants
29-Mar-2022
88.11
8.81
889667
10
Conversion of Warrants
02-Mar-2022
88.11
8.81
889667
10
Conversion of Warrants
31-Mar-2021
79.21
7.92
839997
10
Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Umesh Bhaskar Sandu (14.37%)

Highest Public shareholder

Sanmark Realty And Finance Private Limited (5.63%)

Individual Investors Holdings

35.34%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Dilip R Salgaocar
Non-Exec. & Independent Dir.
41.5 k
Krishna B Deshpande
Non-Exec. & Independent Dir.
0
Madan Laxman Kapre
Non-Exec. & Independent Dir.
53.5 k
K Vinay Kumar
Non-Exec. & Independent Dir.
58.5 k
Shashank B Sandu
Non-Exec & Non-Independent Dir
47.5 k
Umesh B Sandu
Managing Director
71.18 lacs
Shubhada P Sandu
Non-Exec & Non-Independent Dir
25.0 k
Pratika Mhambray
Company Sec. & Compli. Officer
3.16 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of stock in Trade
26.91277
0%
 
100
Purchase of stock in Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Ayurvedic Products
49.16
100.00%
 
100
Ayurvedic Products
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
18 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summary
Industry

Trading

stock-summary
Market cap

INR 46 Cr (Micro Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

22

stock-summary
Dividend Yield

1.67%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

3.60%

stock-summary
Price to Book

1.14